搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
it.benzinga
18 小时
La FDA approva il nuovo farmaco emofilico di Pfizer in anticipo
La FDA approva con sei mesi di anticipo il farmaco Hympavzi di Pfizer, offrendo nuove speranze per i pazienti.
腾讯网
2 天
首款!每周一次,辉瑞长效血友病疗法获FDA批准
▎药明康德内容团队编辑今天,美国FDA批准辉瑞(Pfizer)药品Hympavzi(marstacimab)用于常规预防或减少12岁及以上血友病A和血友病B成人和儿童患者的出血,这些患者体内不含凝血因子VIII与IX抑制剂(中和抗体)。根据新闻稿, ...
3 天
首款每周一次长效血友病疗法获FDA批准 来自辉瑞
当地时间10月11日,美国FDA批准辉瑞(Pfizer)药品Hympavzi(marstacimab)用于常规预防或减少12岁及以上血友病A和血友病B成人和儿童患者的出血,这些患者体内不含凝血因子VIII与IX抑制剂(中和抗体)。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
BP endorses Trump
GOP ad mistake in MI
Human smell study
Rally suspect denies plot
Arrests at the NYSE
Tech founder's murder trial
Harbaugh’s heart scare
Urged to reverse trans ban
Hit with new civil lawsuits
FEMA pauses aid in NC
2,471-pound pumpkin wins
Game Freak data breach
Files for bankruptcy
Rapper Ka dies at 52
Detroit off-duty officer killed
On their way to DC
Approves mpox vaccine
FL power to be restored
COVID linked to diabetes?
MA town fines resident
Indigenous Peoples Day
EU trial about funds
Ethel Kennedy’s funeral
Rare comet spotted
AR casino challenge ruling
BCBS settles antitrust claims
Sued by workers for injuries
Dow, S&P 500 hit records
Medicare open enrollment
反馈